Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Chang Kang and Wan Park.
Connection Strength

2.773
  1. Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection. J Infect Dis. 2021 07 02; 224(1):39-48.
    View in: PubMed
    Score: 0.239
  2. Compassionate use of hzVSF-v13 in two patients with severe COVID-19. J Med Virol. 2020 11; 92(11):2371-2373.
    View in: PubMed
    Score: 0.221
  3. Aberrant hyperactivation of cytotoxic T-cell as a potential determinant of COVID-19 severity. Int J Infect Dis. 2020 Aug; 97:313-321.
    View in: PubMed
    Score: 0.221
  4. In vitro activity of lopinavir/ritonavir and hydroxychloroquine against severe acute respiratory syndrome coronavirus 2 at concentrations achievable by usual doses. Korean J Intern Med. 2020 07; 35(4):782-787.
    View in: PubMed
    Score: 0.221
  5. Virus Isolation from the First Patient with SARS-CoV-2 in Korea. J Korean Med Sci. 2020 Feb 24; 35(7):e84.
    View in: PubMed
    Score: 0.217
  6. Immunogenicity and safety of a novel recombinant protective antigen anthrax vaccine (GC1109), a randomized, single-blind, placebo controlled phase II clinical study. Vaccine. 2019 06 27; 37(29):3820-3824.
    View in: PubMed
    Score: 0.206
  7. Gender affects prognosis of methicillin-resistant Staphylococcus aureus bacteremia differently depending on the severity of underlying disease. Eur J Clin Microbiol Infect Dis. 2018 Jun; 37(6):1119-1123.
    View in: PubMed
    Score: 0.191
  8. 18F-FDG PET and histopathologic findings in a patient with severe fever with thrombocytopenia syndrome. Ticks Tick Borne Dis. 2018 05; 9(4):972-975.
    View in: PubMed
    Score: 0.190
  9. Clinical and Epidemiologic Characteristics of Spreaders of Middle East Respiratory Syndrome Coronavirus during the 2015 Outbreak in Korea. J Korean Med Sci. 2017 May; 32(5):744-749.
    View in: PubMed
    Score: 0.179
  10. Persistence of Neutralizing Antibody Response up to 1 Year After Asymptomatic or Symptomatic SARS-CoV-2 Infection. J Infect Dis. 2021 09 17; 224(6):1097-1099.
    View in: PubMed
    Score: 0.061
  11. Antibody Responses One Year after Mild SARS-CoV-2 Infection. J Korean Med Sci. 2021 May 31; 36(21):e157.
    View in: PubMed
    Score: 0.059
  12. Can reactogenicity predict immunogenicity after COVID-19 vaccination? Korean J Intern Med. 2021 11; 36(6):1486-1491.
    View in: PubMed
    Score: 0.059
  13. Clinical Application of the Standard Q COVID-19 Ag Test for the Detection of SARS-CoV-2 Infection. J Korean Med Sci. 2021 Apr 12; 36(14):e101.
    View in: PubMed
    Score: 0.059
  14. Stereotypic neutralizing VH antibodies against SARS-CoV-2 spike protein receptor binding domain in patients with COVID-19 and healthy individuals. Sci Transl Med. 2021 01 27; 13(578).
    View in: PubMed
    Score: 0.058
  15. Communication: Comparison of Respiratory Specimens for the Detection of SARS-CoV-2. Ann Clin Lab Sci. 2021 Jan; 51(1):140-144.
    View in: PubMed
    Score: 0.058
  16. Antibody Responses 8 Months after Asymptomatic or Mild SARS-CoV-2 Infection. Emerg Infect Dis. 2021 03; 27(3):928-931.
    View in: PubMed
    Score: 0.057
  17. Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection. Emerg Infect Dis. 2021 01; 27(1).
    View in: PubMed
    Score: 0.057
  18. Antibody Responses to SARS-CoV-2 at 8 Weeks Postinfection in Asymptomatic Patients. Emerg Infect Dis. 2020 10; 26(10):2484-2487.
    View in: PubMed
    Score: 0.056
  19. A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance. J Korean Med Sci. 2020 Jun 22; 35(24):e231.
    View in: PubMed
    Score: 0.056
  20. A cluster of tertiary transmissions of 2019 novel coronavirus (SARS-CoV-2) in the community from infectors with common cold symptoms. Korean J Intern Med. 2020 07; 35(4):758-764.
    View in: PubMed
    Score: 0.055
  21. Selecting coronavirus disease 2019 patients with negligible risk of progression: early experience from non-hospital isolation facility in Korea. Korean J Intern Med. 2020 07; 35(4):765-770.
    View in: PubMed
    Score: 0.055
  22. Prospective evaluation of a rapid antimicrobial susceptibility test (QMAC-dRAST) for selecting optimal targeted antibiotics in positive blood culture. J Antimicrob Chemother. 2019 08 01; 74(8):2255-2260.
    View in: PubMed
    Score: 0.052
  23. An Atypical Case of Middle East Respiratory Syndrome in a Returning Traveler to Korea from Kuwait, 2018. J Korean Med Sci. 2018 Dec 31; 33(53):e348.
    View in: PubMed
    Score: 0.050
  24. Effects of Phage Endolysin SAL200 Combined with Antibiotics on Staphylococcus aureus Infection. Antimicrob Agents Chemother. 2018 10; 62(10).
    View in: PubMed
    Score: 0.049
  25. Sudden Deaths of Neonates Receiving Intravenous Infusion of Lipid Emulsion Contaminated with Citrobacter freundii. J Korean Med Sci. 2018 Mar 05; 33(10):e97.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.